NASDAQ: RXRX - Recursion Pharmaceuticals, Inc.

Price = Avg Price + (Avg Price * CAGR EPS% / 100)
EPS = Earning Per Share
CAGR EPS = CAGR 5 EPS
Key Rate — Nøkkelrente
Excess Key Rate — Ønsket overskridelse av styringsrenten
EPS = -1.58
CAGR EPS = 23.47%
Key Rate = 0.0458
Excess Key Rate = 2
Price = 8.41 + (8.41 * 23.47% / 100) = 10.38

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Discount Ebitda / (1 + WACC) ^ 5)
Discount Ebitda(5) = -1.17
Ebitda Yield = 0.3121
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 9.7E-5
Debt = 0.0073
Market Cap = 1.82
Weight Debt = Market Cap / (Market Cap + Debt) = 1.82 / (1.82 + 0.0073) = 0.996
Weight Cost Debt = 100% - 0.996 = 0.004
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.75
β = -1.04
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.75 + -1.04 * 5.94 + 0 = -0.0346
WACC = (9.7E-5 / 0.0073) * (100% - 0.996) * (1 - 0.21) + -0.0346 + 0.996 = 1.01
Terminal Value = Discount (-1.17 * (1 + 0.3121) / (1.01 - 0.3121)) = -4.81
Company Value = ∑ (-1.17 / (1 + 1.01) ^ 5) = -3.51
Price = (Terminal Value + Company Value) / Count shares = (-4.81 + -3.51) / 207850000 = -40.06

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield)
Company Value = ∑ (Discount FCF / (1 + WACC) ^ 5)
Discount FCF(5) = -1.12
FCF Yield = 0.3004
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 9.7E-5
Debt = 0.0073
Market Cap = 1.82
Weight Debt = Market Cap / (Market Cap + Debt) = 1.82 / (1.82 + 0.0073) = 0.996
Weight Cost Debt = 100% - 0.996 = 0.004
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.75
β = -1.04
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.75 + -1.04 * 5.94 + 0 = -0.0346
WACC = (9.7E-5 / 0.0073) * (100% - 0.996) * (1 - 0.21) + -0.0346 + 0.996 = 1.01
Terminal Value = Discount (-1.12 * (1 + 0.3004) / (1.01 - 0.3004)) = -4.76
Company Value = ∑ (-1.12 / (1 + 1.01) ^ 5) = -3.41
Price = (Terminal Value + Company Value) / Count shares = (-4.76 + -3.41) / 207850000 = -39.31